2018
DOI: 10.3390/molecules23040763
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of Polyheterocyclic Pyrrolo[3,4-b]pyridin-5-ones via a One-Pot (Ugi-3CR/aza Diels-Alder/N-acylation/aromatization/SN2) Process. A Suitable Alternative towards Novel Aza-Analogues of Falipamil

Abstract: We describe the one-pot synthesis of twenty polyheterocyclic pyrrolo[3,4-b]pyridin-5-ones via a cascade process (Ugi-3CR/aza Diels-Alder/N-acylation/aromatization) in 20 to 95% overall yields, as well as four pharmacologically promising analogues via an improved cascade process (Ugi-3CR/aza Diels-Alder/N-acylation/aromatization/SN2): two piperazine-linked pyrrolo[3,4-b]pyridin-5-ones in 33 and 34%, and a couple of Falipamil aza-analogues in 30 and 35% overall yields. It is worth highlighting the good substrate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
4
1
1

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 30 publications
0
5
0
Order By: Relevance
“…In our research group, we hold an ongoing program to develop short and versatile MCR-based strategies toward novel and complex polyheterocycles of interest in various fields, like optics [21] and medicinal chemistry [22]. One polyheterocyclic system that we can synthesize à la carte is the pyrrolo[3,4- b ]pyridin-5-one [23], which is considered as a privileged aza-analogue of the isoindolin-1-one [24], the latter being the structural core of various natural and synthetic anticancer agents [25].…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…In our research group, we hold an ongoing program to develop short and versatile MCR-based strategies toward novel and complex polyheterocycles of interest in various fields, like optics [21] and medicinal chemistry [22]. One polyheterocyclic system that we can synthesize à la carte is the pyrrolo[3,4- b ]pyridin-5-one [23], which is considered as a privileged aza-analogue of the isoindolin-1-one [24], the latter being the structural core of various natural and synthetic anticancer agents [25].…”
Section: Resultsmentioning
confidence: 99%
“…In this context, stepwise methodologies have been reported in synthesizing novel pyrrolo[3,4- b ]pyridin-5-ones, for example, Devasthale and co-workers synthesized a panel of pyrrolo[3,4- b ]pyridin-5-ones, evaluating in vitro their properties as inhibitors of the dipeptidyldipentidase-4 (DPP-4) [26]. However, one efficient, versatile, and robust method to construct this polyheterocyclic core is through a one-pot cascade sequence Ugi–3CR/ aza Diels–Alder cycloaddition/ N –acylation/decarboxylation/dehydration, reported first by Zhu and co-workers [27], and further optimized by us many times [22,23,28,29,30,31,32,33,34]. Thus, for the in vitro assays against SiHa, HeLa, and CaSki cell lines, we synthesized some of our previously reported pyrrolo[3,4- b ]pyridin-5-ones 1a – j [22,32], and the new ones 1k – l , specifically prepared for the present study (Figure 1).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Most of the reported methods to assemble pyrrolo [3,4-b]pyridin-5one based architectures involve multistep strategies as well as the use of harsh conditions-see for example the synthetic methodology reported by Devasthale et al [2]. However, various multicomponent reaction (MCR)-based synthetic strategies toward series of novel pyrrolo [3,4b]pyridin-5-one-containing polyheterocycles have been reported in the last decade by us [7][8][9][10][11][12][13][14] as an integral part of our ongoing research program. It is important to note that MCRs are highly convergent one-pot processes in which three or more reagents are combined sequentially to assemble complex products [15] like polyheterocycles [16], eventually in good yields, obeying most of the green chemistry principles [17].…”
Section: Introductionmentioning
confidence: 99%